Blog & Resources
Expert insights on weight loss, GLP-1 medications, and metabolic health — sorted by what's most current.
Weight Loss · February 15, 2026The Next 18 Months of Weight Loss Medicine: What Is Coming After OzempicOzempic was the opening act. Wegovy made it mainstream. Zepbound raised the bar. This guide walks through every major medication in the pipeline, what makes each one different, and what it means for your decision right now.
Treatment · February 14, 2026What Happens When You Stop? Lessons from GLP-1 Discontinuation DataThe honest answer is nuanced. Yes, weight regain after discontinuing GLP-1 medications is real and well-documented. No, it does not mean treatment is pointless. Here is what the clinical data shows and five evidence-based strategies to protect your results.
Liver Health · February 12, 2026Retatrutide and Fatty Liver: Why Metabolic Doctors Are Watching the TRIUMPH TrialsOne in three adults has fatty liver; most do not know. Retatrutide is producing liver fat reduction data that has hepatologists paying close attention. Here is what the numbers show and why this matters.
PCOS · February 10, 2026Retatrutide and PCOS: What Triple Agonism Could Mean for Women's Metabolic HealthGLP-1 medications are already being used off-label for the metabolic component of PCOS. Retatrutide, the first triple agonist in the pipeline, may take that approach significantly further. Here is what we know and what you can do right now.
Muscle Preservation · February 8, 2026GLP-1 and Muscle Preservation: How to Keep Strength While Losing WeightWeight loss on GLP-1 medications can sometimes come with loss of lean mass. Learn evidence-based strategies to preserve muscle while achieving your weight loss goals.